News Results

There are 369,718 News Results

Mar 27, 2019
Novartis receives FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary progressive MS with active disease
EAST HANOVER, N.J., March 27, 2019 /PRNewswire/ --
Mar 28, 2019
Aridis Pharmaceuticals Announces 2018 Fourth Quarter and Year-End Financial Results and Business Update
SAN JOSE, Calif., March 28, 2019 /PRNewswire/ --
Mar 28, 2019
Centrus Energy Corp. Reports Financial Results for the Fourth Quarter and Full Year 2018
BETHESDA, Md., March 28, 2019 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) today reported results for the fourth quarter 2018 and full year ended December 31, 2018.
Mar 28, 2019
CIMZIA® (certolizumab pegol) is Now the First and Only U.S. FDA-Approved Treatment for Non-Radiographic Axial Spondyloarthritis
BRUSSELS, March 28, 2019 /PRNewswire/ --
Mar 28, 2019
Charlotte's Web Holdings, Inc. Reports 2018 Q4 and Year-End Earnings
Q4 revenue increases 21% QoQ to US$21.5 million
Apr 1, 2019
CBD Continues to Accrue Credibility as Major Pharmacies Begin to Offer Products
NEW YORK, April 1, 2019 /PRNewswire/ -- Recently, Walgreens Boot Alliance decided to add cannabidiol, or CBD-based products to its stores following CVS Health in the addition. The two pharmaceutical...
Apr 1, 2019
Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results
SOUTH SAN FRANCISCO, Calif., April 1, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today reported financial results for the fourth quarter and full year ended December 31, 2018 and...
Apr 2, 2019
EXFO reports second quarter results for fiscal 2019
-- Sales increased 14.2% to US$73.9 million, high end of guidance range -- Bookings improved 16.0% to US$76.1 million, book-to-bill ratio of 1.03 -- IFRS net earnings reached US$5.2 million,...
Apr 5, 2019
Indivior's RECOVER(TM) Study Finds Three-quarters of Patients with Moderate to Severe Opioid Use Disorder Who Received 12 monthly Injections of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection were Abstinent from Illicit Opioids One Year Later
SLOUGH, England and RICHMOND, Va., April 5, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced data from two studies evaluating efficacy and long-term safety of once-monthly SUBLOCADE(TM) (buprenorphine extended-release)...
Apr 6, 2019
Indivior Announces New Study Data in Patients with Moderate to Severe Opioid Use Disorder (OUD) at the 50th ASAM Annual Conference
SLOUGH, England and RICHMOND, Va., April 6, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced data from two new studies: the first provides insights into dosing of once-monthly SUBLOCADE(TM)...
36972

Pages

1

Stories of the day

Sep 17, 2025
Babcock signs new $250 million contract with Australian Border Force to keep...
Sep 19, 2025
CACI to Deliver Secure, Reliable Communications to the Air Force – Pacific Air...
Sep 19, 2025
Saab to lead NATOs new underwater battlespace project
Sep 19, 2025
Babcock and BAE Systems Bofors coordinate capabilities for gunnery support